CD8A and psoriasis: Regarding the specific marker of cell proliferation Ki67, the reports from the literature claim that the expression of Ki67-positive cells decreased after a six-week treatment with the vitamin D analog, calcipotriol, topically applied on psoriasis skin, but the effects over dermal inflammation assessed by CD8+ and CD4+ lymphocytes were less conclusive [48].